Zobrazeno 1 - 10
of 736
pro vyhledávání: '"nathan D Wong"'
Autor:
Christopher D Gardner, Nathan D Wong, Matthew J Landry, Jocelyn P Pineda, Jaylen M Lee, Michael A Hoyt, Karen L Edwards, Karen L Lindsay
Publikováno v:
BMJ Open, Vol 14, Iss 11 (2024)
Introduction Despite the importance of the transition to fatherhood as a critical life stage among young adult men, much remains unknown about the factors predictive of ideal cardiovascular health (CVH) and how CVH is impacted as young men face new r
Externí odkaz:
https://doaj.org/article/3004183cf45742d2a5bba96b9d2d4d6d
Autor:
Kevin S Tang, MD MMS, Jeffrey E Jones, BS, Matthew Bang, BS, Wenjun Fan, MD, Nathan D Wong, PhD
Publikováno v:
American Journal of Preventive Cardiology, Vol 15, Iss , Pp 100553- (2023)
Therapeutic Area: Diabetes Background: Hypertension (HTN) and diabetes mellitus (DM) are both leading contributors to the development of cardiovascular disease (CVD). Furthermore, HTN subtypes may impact CVD outcomes to varying degrees. Data are limi
Externí odkaz:
https://doaj.org/article/3cecdf3539db4032bcfe3426d543c800
Autor:
Mitra Mosslemi, Nathan D Wong
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 9, Iss 1 (2021)
Externí odkaz:
https://doaj.org/article/b4ea908878f5476493553059cce5a4bd
Autor:
Ezra A. Amsterdam, MD, Roger S. Blumenthal, MD, FACC, FAHA, Nathan D. Wong, PhD, FACC, FAHA, FNLA
Endorsed by the American Society for Preventive Cardiology, this highly practical resource focuses on the application of current guidelines and practice standards in the clinical management of cardiovascular risk factors. The Manual presents concise
Autor:
Erin D. Michos, Nathan D. Wong
Publikováno v:
American Journal of Preventive Cardiology, Vol 11, Iss , Pp 100377- (2022)
Externí odkaz:
https://doaj.org/article/a459888998eb4154ba2196db86b60fe3
Autor:
Nathan D. Wong, Matthew J. Budoff, Keith Ferdinand, Ian M. Graham, Erin D. Michos, Tina Reddy, Michael D. Shapiro, Peter P. Toth
Publikováno v:
American Journal of Preventive Cardiology, Vol 10, Iss , Pp 100335- (2022)
Risk for atherosclerotic cardiovascular disease (ASCVD) shows considerable heterogeneity both in generally healthy persons and in those with known ASCVD. The foundation of preventive cardiology begins with assessing baseline ASCVD risk using global r
Externí odkaz:
https://doaj.org/article/9d07f686960c4ef4a9c271ae80518d9c
The potential population health impact of treating REDUCE-IT eligible US adults with Icosapent Ethyl
Autor:
Catherine G. Derington, Adam P. Bress, Jennifer S. Herrick, Wenjun Fan, Nathan D. Wong, Katherine E. Andrade, Jonathan Johnson, Sephy Philip, David Abrahamson, Lixia Jiao, Deepak L. Bhatt, William S. Weintraub
Publikováno v:
American Journal of Preventive Cardiology, Vol 10, Iss , Pp 100345- (2022)
Objective: To explore the population health impact of treating all US adults eligible for the Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial (REDUCE-IT) with icosapent ethyl (IPE), we estimated (1) the number of ASCVD ev
Externí odkaz:
https://doaj.org/article/b31da22a6f9b4f23991ab816b9424c63
Autor:
Dragan Kalinić, Ranko Škrbić, Duško Vulić, Nataša Stojaković, Svjetlana Stoisavljević-Šatara, Miloš P. Stojiljković, Vanda Marković-Peković, Ana Golić Jelić, Nataša Pilipović-Broćeta, Nathan D. Wong, Brian Godman
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: In last 2 decades, there have been substantial changes in the utilization patterns of antihypertensive medicines following new clinical trials and the introduction of new treatment guidelines. The aim of this study was to analyze utilizat
Externí odkaz:
https://doaj.org/article/78115da49c95479baff00e669ef5b5eb
Autor:
Nathan D. Wong, Erin D. Michos
Publikováno v:
American Journal of Preventive Cardiology, Vol 10, Iss , Pp 100351- (2022)
Externí odkaz:
https://doaj.org/article/e8c66021c7c5435db90ca3180bd1f5ac
Publikováno v:
American Journal of Preventive Cardiology, Vol 10, Iss , Pp 100336- (2022)
Objective: To update the prevalence of atherosclerotic cardiovascular disease (ASCVD) in the United States (US) and re-evaluate lipid-lowering therapies (LLT) utilization and low-density lipoprotein cholesterol (LDL-C) goal attainment among ASCVD pat
Externí odkaz:
https://doaj.org/article/642ba85582cf4731ba22248d0bae18e1